BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9843990)

  • 1. Susceptibility to the biological effects of polyaromatic hydrocarbons is influenced by genes of the major histocompatibility complex.
    Elmets CA; Athar M; Tubesing KA; Rothaupt D; Xu H; Mukhtar H
    Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14915-9. PubMed ID: 9843990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis.
    Yusuf N; Nasti TH; Long JA; Naseemuddin M; Lucas AP; Xu H; Elmets CA
    Cancer Res; 2008 Jan; 68(2):615-22. PubMed ID: 18199559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Suppression of Heat Shock Protein (HSP)27 and HSP70 Accelerates DMBA-Induced Skin Carcinogenesis by Inducing Antigenic Unresponsiveness to the Initiating Carcinogenic Chemical.
    Yusuf N; Nasti TH; Ahmad I; Chowdhury S; Mohiuddin H; Xu H; Athar M; Timares L; Elmets CA
    J Immunol; 2015 May; 194(10):4796-803. PubMed ID: 25840912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonistic roles of CD4+ and CD8+ T-cells in 7,12-dimethylbenz(a)anthracene cutaneous carcinogenesis.
    Yusuf N; Nasti TH; Katiyar SK; Jacobs MK; Seibert MD; Ginsburg AC; Timares L; Xu H; Elmets CA
    Cancer Res; 2008 May; 68(10):3924-30. PubMed ID: 18483278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol enhances cell-mediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesis.
    Yusuf N; Nasti TH; Meleth S; Elmets CA
    Mol Carcinog; 2009 Aug; 48(8):713-23. PubMed ID: 19142898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired and innate immunity to polyaromatic hydrocarbons.
    Yusuf N; Timares L; Seibert MD; Xu H; Elmets CA
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):308-12. PubMed ID: 17258781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of contact hypersensitivity to dimethylbenz(a)anthracene and benzo(a)pyrene in C3H/HeN mice.
    Klemme JC; Mukhtar H; Elmets CA
    Cancer Res; 1987 Nov; 47(22):6074-8. PubMed ID: 3117362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired immunological surveillance by 7,12-dimethylbenz(a)anthracene augments its skin tumorigenicity in C3H mice.
    Elmets CA; Khan WA; Klemme JC; Mukhtar H
    Biochem Biophys Res Commun; 1988 Feb; 151(1):148-52. PubMed ID: 3126733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of carcinogenic potency with mouse-skin 32P-postlabeling and muta-Rmouse lac Z- mutation data for DMBA and its K-region sulphur isostere: comparison with activities observed in standard genotoxicity assays.
    Ashby J; Brusick D; Myhr BC; Jones NJ; Parry JM; Nesnow S; Paton D; Tinwell H; Rosenkranz HS; Curti S
    Mutat Res; 1993 Aug; 292(1):25-40. PubMed ID: 7688094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
    Iversen OH
    APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoprevention of chemical carcinogenesis through early recognition of oncogene mutations.
    Nasti TH; Rudemiller KJ; Cochran JB; Kim HK; Tsuruta Y; Fineberg NS; Athar M; Elmets CA; Timares L
    J Immunol; 2015 Mar; 194(6):2683-95. PubMed ID: 25694611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenetic influences on the initiation stage of the cutaneous chemical carcinogenesis pathway.
    Elmets CA; Zaidi SI; Bickers DR; Mukhtar H
    Cancer Res; 1992 Nov; 52(21):6106-9. PubMed ID: 1394238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypic differences in host immunoreactivity and their effect on the development of polycyclic hydrocarbon-induced tumors.
    Elmets CA; Anderson CY; Mukhtar H
    Environ Toxicol Pharmacol; 1997 Dec; 4(3-4):289-93. PubMed ID: 21781835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of initiating doses of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene on the expression of PAH activating enzymes and its modulation by plant phenols.
    Szaefer H; Krajka-Kuźniak V; Baer-Dubowska W
    Toxicology; 2008 Sep; 251(1-3):28-34. PubMed ID: 18694800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Comparative Initiation/Promotion Skin Paint Studies of B6C3F1 Mice, Swiss (CD-1(R)) Mice, and SENCAR Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Feb; 441():1-201. PubMed ID: 12595922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both (+/-)syn- and (+/-)anti-7,12-dimethylbenz[a]anthracene-3,4-diol-1,2-epoxides initiate tumors in mouse skin that possess -CAA- to -CTA- mutations at Codon 61 of c-H-ras.
    Tang MS; Vulimiri SV; Viaje A; Chen JX; Bilolikar DS; Morris RJ; Harvey RG; Slaga TJ; DiGiovanni J
    Cancer Res; 2000 Oct; 60(20):5688-95. PubMed ID: 11059761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of CYP1A1 and CYP1B1 in liver and lung by benzo(a)pyrene and 7,12-d imethylbenz(a)anthracene do not affect distribution of polycyclic hydrocarbons to target tissue: role of AhR and CYP1B1 in bone marrow cytotoxicity.
    Galván N; Teske DE; Zhou G; Moorthy B; MacWilliams PS; Czuprynski CJ; Jefcoate CR
    Toxicol Appl Pharmacol; 2005 Feb; 202(3):244-57. PubMed ID: 15667830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between formation of a specific hydrocarbon-deoxyribonucleoside adduct and tumor-initiating activity of 7,12-dimethylbenz(a)anthracene and its 9- and 10-monofluoroderivatives in mice.
    DiGiovanni J; Sawyer TW; Fisher EP
    Cancer Res; 1986 Sep; 46(9):4336-41. PubMed ID: 3089589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to chlamydial lung infection is dependent on major histocompatibility complex as well as non-major histocompatibility complex determinants.
    Qiu H; Wang S; Yang J; Fan Y; Joyee AG; Han X; Jiao L; Yang X
    Immunology; 2005 Dec; 116(4):499-506. PubMed ID: 16313363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1alpha up-regulation in vivo by a potent carcinogen 7,12-dimethylbenz(a)anthracene (DMBA) and control of DMBA-induced inflammatory responses.
    Li X; Eckard J; Shah R; Malluck C; Frenkel K
    Cancer Res; 2002 Jan; 62(2):417-23. PubMed ID: 11809690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.